Income Statement ROQT THER OTC Markets

Stocks

ROQAF

GB00BMDQ2T15

Market Closed - OTC Markets Other stock markets 12:35:24 2026-07-24 EDT			5-day change	1st Jan Change
0.1420 ^USD	+8.60%		0.00%	-33.49%

05-05	Roquefort Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-27	Coiled Therapeutics Inc. completed the acquisition of Roquefort Therapeutics plc in a reverse merger transaction.	CI

4fe17d4c.B0Yf3N0ZZGw3pigGt0q0ccEGngXJLw1tSK7dxO6pqSI.dxNlu55IUT9e1EFp8Rj6M6hD-HWTQ1knGPfriITh3EBOcUeltywKWmfDEA

Published financial data: ROQT THER

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	539	-	200K	-	-
Other Revenues, Total	98	-	-	-	-
Total Revenues	637	-	200K	-	-
Cost of Goods Sold, Total	7.55K	-	-	16K	-
Gross Profit	-6.92K	-	200K	-16K	-
Selling General & Admin Expenses, Total	376K	1.31M	1.51M	943K	684K
R&D Expenses	524	319K	620K	153K	150K
Depreciation & Amortization - (IS)	-	-	3.89K	5.4K	4.95K
Other Operating Expenses	-	-	-	-	-16.18K
Other Operating Expenses, Total	376K	1.63M	2.13M	1.1M	822K
Operating Income	-383K	-1.63M	-1.93M	-1.12M	-822K
Interest Expense, Total	-	-	-58	-44.86K	-37.97K
Interest And Investment Income	-	-	1.47K	-	-
Net Interest Expenses	-	-	1.41K	-44.86K	-37.97K
Other Non Operating Income (Expenses)	-137K	-	-	-52.79K	-17.29K
EBT, Excl. Unusual Items	-520K	-1.63M	-1.93M	-1.21M	-877K
Merger & Related Restructuring Charges	-169K	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-39.79K
Asset Writedown	-	-	-	-	-2.49M
EBT, Incl. Unusual Items	-688K	-1.63M	-1.93M	-1.21M	-3.4M
Income Tax Expense	-	-18.89K	-188K	-243K	-41.89K
Earnings From Continuing Operations	-688K	-1.62M	-1.74M	-972K	-3.36M
Net Income to Company	-688K	-1.62M	-1.74M	-972K	-3.36M
Net Income - (IS)	-688K	-1.62M	-1.74M	-972K	-3.36M
Net Income to Common Incl Extra Items	-688K	-1.62M	-1.74M	-972K	-3.36M
Net Income to Common Excl. Extra Items	-688K	-1.62M	-1.74M	-972K	-3.36M
Per Share Items
Net EPS - Basic	-0.28	-0.16	-0.14	-0.07	-0.22
Basic EPS - Continuing Operations	-0.28	-0.16	-0.14	-0.07	-0.22
Basic Weighted Average Shares Outstanding	2.47M	10.35M	12.92M	13M	15.36M
Net EPS - Diluted	-0.28	-0.16	-0.14	-0.08	-0.22
Diluted EPS - Continuing Operations	-0.28	-0.16	-0.14	-0.08	-0.22
Diluted Weighted Average Shares Outstanding	2.47M	10.35M	12.92M	13M	15.36M
Normalized Basic EPS	-0.13	-0.1	-0.09	-0.06	-0.04
Normalized Diluted EPS	-0.13	-0.1	-0.09	-0.06	-0.04
Supplemental Items
EBITDA	-	-	-1.93M	-1.11M	-817K
EBITA	-383K	-1.63M	-1.93M	-1.12M	-822K
EBIT	-383K	-1.63M	-1.93M	-1.12M	-822K
Effective Tax Rate - (Ratio)	-	1.16	9.71	19.99	1.23
Normalized Net Income	-325K	-1.02M	-1.21M	-759K	-548K
Supplemental Operating Expense Items
General and Administrative Expenses	376K	1.31M	1.51M	943K	684K
Research And Development Expense From Footnotes	524	319K	620K	153K	150K
Stock-Based Comp., G&A Exp. (Total)	186K	8.43K	10.4K	10.96K	-
Stock-Based Comp., Other (Total)	88.79K	-	-	-	-
Total Stock-Based Compensation	275K	8.43K	10.4K	10.96K	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	900K	2.32M	537K	337K	78.05K
Total Cash And Short Term Investments	900K	2.32M	537K	337K	78.05K
Accounts Receivable, Total	17.82K	-	-	-	-
Other Receivables	2.14M	45.12K	105K	14.19K	27.9K
Total Receivables	2.15M	45.12K	105K	14.19K	27.9K
Prepaid Expenses	25.93K	56.61K	52.35K	11.19K	12.46K
Total Current Assets	3.08M	2.42M	695K	362K	118K
Gross Property Plant And Equipment	-	-	54.04K	-	-
Accumulated Depreciation	-	-	-3.89K	-	-
Net Property Plant And Equipment	-	-	50.15K	44.75K	-
Goodwill	282K	282K	282K	282K	-
Other Intangibles, Total	1.2M	5.06M	5.06M	5.06M	2.57M
Total Assets	4.56M	7.77M	6.09M	5.75M	2.69M
Liabilities
Accounts Payable, Total	40.72K	68.38K	145K	23.03K	135K
Accrued Expenses, Total	155K	211K	162K	157K	139K
Short-term Borrowings	-	-	-	400K	-
Total Current Liabilities	196K	280K	307K	580K	273K
Deferred Tax Liability Non Current	282K	282K	282K	282K	-
Total Liabilities	477K	562K	589K	862K	273K
Common Stock, Total	719K	1.29M	1.29M	1.36M	1.64M
Additional Paid In Capital	3.91M	4.4M	4.4M	4.62M	4.76M
Retained Earnings	-914K	-2.55M	-4.29M	-5.27M	-8.4M
Comprehensive Income and Other	367K	4.06M	4.1M	4.18M	4.42M
Total Common Equity	4.08M	7.21M	5.5M	4.89M	2.42M
Total Equity	4.08M	7.21M	5.5M	4.89M	2.42M
Total Liabilities And Equity	4.56M	7.77M	6.09M	5.75M	2.69M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	7.19M	12.92M	12.92M	13.57M	16.37M
ECS Total Common Shares Outstanding	7.19M	12.92M	12.92M	13.57M	16.37M
Book Value / Share	0.57	0.56	0.43	0.36	0.15
Tangible Book Value	2.6M	1.86M	156K	-454K	-155K
Tangible Book Value Per Share	0.36	0.14	0.01	-0.03	-0.01
Total Debt	0	0	0	400K	0
Net Debt	-900K	-2.32M	-537K	62.98K	-78.05K
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	-	-	54.04K	-	-
Full Time Employees	1	9	10	7	6

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-688K	-1.62M	-1.74M	-972K	-3.36M
Depreciation & Amortization - CF	-	-	3.89K	5.4K	4.95K
Depreciation & Amortization, Total	-	-	3.89K	5.4K	4.95K
(Gain) Loss From Sale Of Asset	-	-	-	-	39.79K
Asset Writedown & Restructuring Costs	-	-	-	-	2.49M
Stock-Based Compensation (CF)	275K	8.43K	10.4K	21.46K	-
Other Operating Activities, Total	-60.35K	-9.92K	25.12K	152K	13.26K
Change In Accounts Receivable	-1.6M	-20.32K	-55.85K	130K	-16.53K
Change In Inventories	6.96K	-	-	-	-
Change In Accounts Payable	97.14K	59.75K	27.44K	-121K	188K
Cash from Operations	-1.97M	-1.58M	-1.73M	-784K	-646K
Capital Expenditure	-	-	-54.04K	-	-
Cash Acquisitions	-830K	-103K	-	-	-
Other Investing Activities, Total	-	-	1.47K	-	-
Cash from Investing	-830K	-103K	-52.57K	-	-
Short Term Debt Issued, Total	-	-	-	585K	-
Total Debt Issued	-	-	-	585K	-
Issuance of Common Stock	3.59M	3.12M	-	-	386K
Other Financing Activities, Total	-120K	-18.99K	-58	-	-
Cash from Financing	3.47M	3.1M	-58	585K	386K
Foreign Exchange Rate Adjustments	-461	2K	512	-1.39K	565
Net Change in Cash	675K	1.42M	-1.79M	-200K	-259K
Supplemental Items
Cash Interest Paid	-	-	58	-	-
Levered Free Cash Flow	-	1.15M	-1.28M	-705K	-454K
Unlevered Free Cash Flow	-	1.15M	-1.28M	-677K	-430K
Change In Net Working Capital	-	-2.16M	28.41K	-4.82K	-78.72K
Net Debt Issued / Repaid	-	-	-	585K	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-	-16.57	-17.44	-11.79	-12.17
Return on Total Capital	-	-18.1	-19.02	-12.94	-13.33
Return On Equity %	-	-28.62	-27.46	-18.71	-92
Return on Common Equity	-	-28.62	-27.46	-18.71	-92
Margin Analysis
Gross Profit Margin %	-1.09K	-	100	-	-
SG&A Margin	58.95K	-	754.8	-	-
EBITDA Margin %	-	-	-964.88	-	-
EBITA Margin %	-60.12K	-	-966.82	-	-
EBIT Margin %	-60.12K	-	-966.82	-	-
Income From Continuing Operations Margin %	-108K	-	-872.27	-	-
Net Income Margin %	-108K	-	-872.27	-	-
Net Avail. For Common Margin %	-108K	-	-872.27	-	-
Normalized Net Income Margin	-50.97K	-	-603.82	-	-
Levered Free Cash Flow Margin	-	-	-638.36	-	-
Unlevered Free Cash Flow Margin	-	-	-638.34	-	-
Asset Turnover
Asset Turnover	-	-	0.03	-	-
Short Term Liquidity
Current Ratio	15.75	8.67	2.26	0.63	0.43
Quick Ratio	15.61	8.47	2.09	0.61	0.39
Operating Cash Flow to Current Liabilities	-10.06	-5.64	-5.64	-1.35	-2.36
Average Days Payable Outstanding	-	-	-	1.92K	-
Long Term Solvency
Total Debt/Equity	-	-	-	8.18	-
Total Debt / Total Capital	-	-	-	7.56	-
Total Liabilities / Total Assets	10.47	7.23	9.67	14.98	10.15
EBIT / Interest Expense	-	-	-33.34K	-24.9	-21.65
EBITDA / Interest Expense	-	-	-33.27K	-24.78	-21.52
(EBITDA - Capex) / Interest Expense	-	-	-34.2K	-24.78	-21.52
Total Debt / EBITDA	-	-	-	-0.36	-
Net Debt / EBITDA	-	-	0.28	-0.06	0.1
Total Debt / (EBITDA - Capex)	-	-	-	-0.36	-
Net Debt / (EBITDA - Capex)	-	-	0.27	-0.06	0.1
Growth Over Prior Year
Gross Profit, 1 Yr. Growth %	-	-	-	-108	-
EBITDA, 1 Yr. Growth %	-	-	-	-42.4	-26.5
EBITA, 1 Yr. Growth %	-	326.74	18.32	-42.24	-26.41
EBIT, 1 Yr. Growth %	-	326.74	18.32	-42.24	-26.41
Earnings From Cont. Operations, 1 Yr. Growth %	-	134.77	7.99	-44.29	245.96
Net Income, 1 Yr. Growth %	-	134.77	7.99	-44.29	245.96
Normalized Net Income, 1 Yr. Growth %	-	214.58	18.23	-37.14	-27.78
Diluted EPS Before Extra, 1 Yr. Growth %	-	-43.96	-13.47	-44.44	192
Net Property, Plant and Equip., 1 Yr. Growth %	-	-	-	-10.78	-
Total Assets, 1 Yr. Growth %	-	70.35	-21.62	-5.55	-53.17
Tangible Book Value, 1 Yr. Growth %	-	-28.37	-91.62	-391.27	-65.89
Common Equity, 1 Yr. Growth %	-	76.52	-23.69	-11.1	-50.51
Cash From Operations, 1 Yr. Growth %	-	306.96	9.89	-54.79	-17.62
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-211.19	-44.79	-34.65
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-211.19	-46.98	-35.47
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	1.67K	-	-
Gross Profit, 2 Yr. CAGR %	-	-	437.8	-	-
EBITDA, 2 Yr. CAGR %	-	-	-	-	-34.93
EBITA, 2 Yr. CAGR %	-	-	124.7	-17.33	-34.8
EBIT, 2 Yr. CAGR %	-	-	124.7	-17.33	-34.8
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	59.23	-22.44	38.82
Net Income, 2 Yr. CAGR %	-	-	59.23	-22.44	38.82
Normalized Net Income, 2 Yr. CAGR %	-	-	92.85	-13.79	-32.62
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-30.36	-30.69	27.37
Total Assets, 2 Yr. CAGR %	-	-	15.55	-13.96	-33.49
Tangible Book Value, 2 Yr. CAGR %	-	-	-75.51	-50.61	-0.33
Common Equity, 2 Yr. CAGR %	-	-	16.06	-17.63	-33.67
Cash From Operations, 2 Yr. CAGR %	-	-	111.48	-29.51	-38.97
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-21.64	-40.38
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-23.22	-41.96
Compound Annual Growth Rate Over Three Years
Gross Profit, 3 Yr. CAGR %	-	-	-	32.26	-
EBITA, 3 Yr. CAGR %	-	-	-	42.87	-20.47
EBIT, 3 Yr. CAGR %	-	-	-	42.87	-20.47
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	12.2	27.68
Net Income, 3 Yr. CAGR %	-	-	-	12.2	27.68
Normalized Net Income, 3 Yr. CAGR %	-	-	-	32.72	-18.73
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-35.43	11.94
Total Assets, 3 Yr. CAGR %	-	-	-	8.04	-29.75
Tangible Book Value, 3 Yr. CAGR %	-	-	-	-44.09	-56.35
Common Equity, 3 Yr. CAGR %	-	-	-	6.19	-30.5
Cash From Operations, 3 Yr. CAGR %	-	-	-	26.45	-25.75
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	-26.61
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	-27.92